FDA announces Class 1 endovascular system, anesthesia system recalls
Editor's Note The US Food and Drug Administration (FDA) designated Getinge’s recall of Vaporizer Sevoflurane Maquet Filling and Sevoflurane Quick-Fil and Philips’ recall of Tack Endovascular Systems as Class 1s, the most severe category indicating serious risk of injury or death. The Getinge recall is an expansion of a 2024…
ACS, SVS verify first four hospitals in Vascular Verification Program
Editor's Note The American College of Surgeons (ACS) and Society for Vascular Surgery (SVS) announced on June 14 that they had verified the first four hospitals as part of the recently launched Vascular Verification Program (Vascular-VP). To receive verification, these hospitals displayed a commitment to improving outcomes and delivering the…
Value assessment of a trauma hybrid OR
Editor's Note This study from the University of Florida Health, Gainesville, examines the complications, cost-utility, and value of a dedicated trauma-endovascular hybrid OR. A total of 292 trauma patients, who underwent immediate operative intervention at a Level I trauma center (106 before construction of a hybrid OR and 186 after…
Free Daily News
- Study: Cataract surgery increases diabetic retinopathy progression
- FDA announces Class 1 endovascular system, anesthesia system recalls
- Cost-shifting concerns rise as GOP eyes Medicaid cuts
- Study: Prolonged general anesthesia linked to long-term cognitive decline
- Real-time cancer detection improves brain surgery precision
- Research highlights anesthesia provider knowledge gap on drug, hormonal contraceptive interactions
- Healthcare CFOs prioritize cost control, data-driven decisions
- Study links intraoperative synthetic opioids, worse postoperative pain
- Tooth-in-eye surgery offers hope for restored vision
- Tenet Healthcare's strategic ASC expansion, hospital divestitures boost 2024 Q4 results